| 2.575 -0.015 (-0.58%) | 03-13 15:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.21 | 1-year : | 3.75 |
| Resists | First : | 2.75 | Second : | 3.21 |
| Pivot price | 2.44  |
|||
| Supports | First : | 2.07 | Second : | 1.65 |
| MAs | MA(5) : | 2.61  |
MA(20) : | 2.28 |
| MA(100) : | 3.06 |
MA(250) : | 3.67 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 86.9 |
D(3) : | 88.4 |
| RSI | RSI(14): 55.2 |
|||
| 52-week | High : | 4.76 | Low : | 1.65 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CLVT ] has closed below upper band by 37.4%. Bollinger Bands are 43.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 2.72 - 2.74 | 2.74 - 2.75 |
| Low: | 2.52 - 2.53 | 2.53 - 2.55 |
| Close: | 2.56 - 2.59 | 2.59 - 2.61 |
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Thu, 12 Mar 2026
Is Clarivate Plc (CLVT) One of the Best Penny Stocks to Buy According to Reddit? - Insider Monkey
Tue, 10 Mar 2026
Clarivate Brings Trusted Regulatory Intelligence To Claude's AI Ecosystem - Benzinga
Tue, 10 Mar 2026
Clarivate Expands Access to Trusted Regulatory Intelligence Within Claude - PR Newswire
Tue, 10 Mar 2026
AI that understands regulations: Clarivate feeds life sciences data into Claude - Stock Titan
Mon, 09 Mar 2026
Clarivate: Deleveraging And FCF Growth Support A Re-Rating - Seeking Alpha
Mon, 09 Mar 2026
Clarkston Capital Partners LLC Sells 3,321,993 Shares of Clarivate PLC $CLVT - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Technology
|
|
|
Industry:
Information Technology Services
|
|
| Shares Out | 641 (M) |
| Shares Float | 477 (M) |
| Held by Insiders | 17.5 (%) |
| Held by Institutions | 87 (%) |
| Shares Short | 61,220 (K) |
| Shares Short P.Month | 47,320 (K) |
| EPS | -0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 7.55 |
| Profit Margin | -8.2 % |
| Operating Margin | 9.3 % |
| Return on Assets (ttm) | 0.9 % |
| Return on Equity (ttm) | -4.1 % |
| Qtrly Rev. Growth | -7 % |
| Gross Profit (p.s.) | 2.52 |
| Sales Per Share | 3.83 |
| EBITDA (p.s.) | 1.45 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 629 (M) |
| Levered Free Cash Flow | 520 (M) |
| PE Ratio | -8.59 |
| PEG Ratio | 0 |
| Price to Book value | 0.34 |
| Price to Sales | 0.67 |
| Price to Cash Flow | 2.62 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|